Patents by Inventor Patrice Viens

Patrice Viens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE EXPRESSION PROFILING OF PRIMARY BREAST CARCINOMAS USING ARRAYS OF CANDIDATE GENES
    Publication number: 20130079234
    Abstract: A method for predicting the sensitivity of tumor cells to an anthracycline-based chemotherapy includes determining the differential expression level of a MYBL2 gene in tumors cells. A polynucleotide library is useful to predict the sensitivity of tumor cells to an anthracycline-based chemotherapy and includes a pool of polynucleotide sequences or subsequences thereof wherein the sequences or subsequences correspond substantially to any of the polynucleotide sequences SEQ ID No: 308, SEQ ID No: 309 and/or SEQ ID No: 310 or the complements thereof.
    Type: Application
    Filed: May 26, 2011
    Publication date: March 28, 2013
    Applicants: Institut Paoli-Calmettes, IPSOGEN, SAS
    Inventors: Francois Bertucci, Rémi Houlgatte, Daniel Birnbaum, Catherine Nguyen, Patrice Viens, Vincent Fert
  • GENE EXPRESSION PROFILING OF PRIMARY BREAST CARCINOMAS USING ARRAYS OF CANDIDATE GENES
    Publication number: 20110086765
    Abstract: Method for molecular characterization of a carcinoma including: (i) detecting in tumor cells corresponding to breast tumor cells at least one polynucleotide selected from a first group determining expression level of the polynucleotide from the first group to differentiate a tumor in which a lymph node has been invaded by a tumor cell from a tumor in which a lymph node has not been invaded by a tumor cell; (ii) detecting in tumor cells corresponding to breast tumor cells at least one polynucleotide selected from a second group determining expression level of the polynucleotide from the second group to distinguish tumors sensitive to anthracycline from tumors insensitive to anthracycline; (iii) detecting in tumor cells corresponding to breast tumor cells at least one polynucleotide selected from a third group determining expression levels of the polynucleotide from the third group to classify good and poor prognosis primary breast tumors.
    Type: Application
    Filed: October 13, 2010
    Publication date: April 14, 2011
    Applicants: IPSOGEN, SAS, Institut Paoli-Calmettes
    Inventors: Francois Bertucci, Rémi Houlgatte, Daniel Birnbaum, Catherine Nguyen, Patrice Viens, Vincent Fert
  • METHODS OF ASSESSING A PROPENSITY OF CLINICAL OUTCOME FOR A FEMALE MAMMAL SUFFERING FROM BREAST CANCER
    Publication number: 20100234292
    Abstract: The present invention relates to a method of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer in view of the expression of specific nucleic acid sequences in a biological sample.
    Type: Application
    Filed: April 16, 2008
    Publication date: September 16, 2010
    Applicants: IPSOGEN, INSERM - INSTITUT NATIONAL DE LA SANTE ET DE LA RE CHECHE MEDICALE, INSTITUT PAOLI-CALMETTES
    Inventors: Francois Bertucci, Daniel Birnbaum, Patrice Viens, Vincent Fert, Fabienne Hermitte, Stephane Debono, Stephane Deraco, Nathalie Borie, Fanny Piette
  • Gene expression profiling of primary breast carcinomas using arrays of candidate genes
    Publication number: 20030143539
    Abstract: A polynucleotide library useful in the molecular characterization of a carcinoma, the library including a pool of polynucleotide sequences or subsequences thereof wherein the sequences or subsequences are overexpressed in tumor cells, further wherein the sequences or subsequences correspond substantially to any of the polynucleotide sequences set forth in any of SEQ ID NOS: 1-468 or the complement thereof.
    Type: Application
    Filed: December 7, 2001
    Publication date: July 31, 2003
    Inventors: Francois Bertucci, Remi Houlgatte, Daniel Birnbaum, Catherine Nguyen, Patrice Viens, Vincent Fert